Universal Beteiligungs und Servicegesellschaft mbH Has $30.84 Million Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Universal Beteiligungs und Servicegesellschaft mbH increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.4% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 410,634 shares of the company’s stock after purchasing an additional 17,335 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.09% of GE HealthCare Technologies worth $30,839,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in GEHC. Vanguard Group Inc. grew its stake in GE HealthCare Technologies by 1.4% during the second quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock worth $3,859,622,000 after buying an additional 703,903 shares during the last quarter. Dodge & Cox grew its position in GE HealthCare Technologies by 42.1% during the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after acquiring an additional 6,982,441 shares during the last quarter. State Street Corp grew its position in GE HealthCare Technologies by 1.9% during the 2nd quarter. State Street Corp now owns 19,660,742 shares of the company’s stock worth $1,456,271,000 after acquiring an additional 372,755 shares during the last quarter. Geode Capital Management LLC increased its holdings in GE HealthCare Technologies by 2.0% during the 2nd quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company’s stock valued at $881,060,000 after purchasing an additional 231,302 shares in the last quarter. Finally, Norges Bank bought a new position in GE HealthCare Technologies in the 2nd quarter valued at $468,120,000. 82.06% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have recently weighed in on GEHC shares. BTIG Research restated a “buy” rating and issued a $87.00 target price on shares of GE HealthCare Technologies in a research note on Friday, November 21st. Wells Fargo & Company lowered their price objective on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research report on Thursday, October 30th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $98.00 target price on shares of GE HealthCare Technologies in a research note on Friday, January 9th. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and increased their price target for the company from $73.00 to $77.00 in a research note on Thursday, January 15th. Finally, Stifel Nicolaus boosted their price objective on shares of GE HealthCare Technologies from $90.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, January 7th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $89.83.

GE HealthCare Technologies Stock Up 1.0%

Shares of NASDAQ:GEHC opened at $81.89 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. The stock has a market cap of $37.30 billion, a price-to-earnings ratio of 16.92, a P/E/G ratio of 2.45 and a beta of 1.08. The company has a 50 day moving average of $81.85 and a 200-day moving average of $77.17. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $5.07 billion. During the same period last year, the firm earned $1.14 earnings per share. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be paid a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.